Jeil Pharma Holdings (XKRX:002620) Change In Receivables : ₩7,231 Mil (TTM As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Change In Receivables?

Jeil Pharma Holdings's change in receivables for the quarter that ended in Mar. 2024 was ₩4,784 Mil. It means Jeil Pharma Holdings's Accounts Receivable declined by ₩4,784 Mil from Dec. 2023 to Mar. 2024 .

Jeil Pharma Holdings's change in receivables for the fiscal year that ended in Dec. 2023 was ₩-13,783 Mil. It means Jeil Pharma Holdings's Accounts Receivable increased by ₩13,783 Mil from Dec. 2022 to Dec. 2023 .

Jeil Pharma Holdings's Accounts Receivable for the quarter that ended in Mar. 2024 was ₩175,463 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Jeil Pharma Holdings's Days Sales Outstanding for the three months ended in Mar. 2024 was 84.79.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Jeil Pharma Holdings's liquidation value for the three months ended in Mar. 2024 was ₩-226,706 Mil.

Jeil Pharma Holdings Change In Receivables Historical Data

The historical data trend for Jeil Pharma Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Change In Receivables Chart

Jeil Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

8,298.46

4,993.35

7,216.36

-11,937.11

-13,782.98

Jeil Pharma Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-16,229.86	18,178.79	-14,849.11	-882.79	4,784.43

Jeil Pharma Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,231 Mil.

Jeil Pharma Holdings (XKRX:002620) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Jeil Pharma Holdings's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	175463.351	/	188831.48	*	91
=	84.79

2. In Ben Graham's calculation of liquidation value, Jeil Pharma Holdings's accounts receivable are only considered to be worth 75% of book value:

Jeil Pharma Holdings's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	55878.201	-	480573.638	+	0.75 * 175463.351	+	0.5 * 132782.904
=	-226,706

Jeil Pharma Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Jeil Pharma Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810

Website

https://www.jeilpharm.co.kr

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines